BIOCQ Dividend: Biocept Inc Yield Insights

Breakdown	TTM	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
营收	1	25	61	27	5	3
营收同比增长 (YoY)	-98%	-59%	126%	440%	67%	-40%
营收成本	15	28	37	21	10	10
毛利润	-14	-2	23	6	-5	-6
销售、一般及管理费用	14	23	20	16	12	12
研发	4	6	4	5	4	4
营业费用	18	29	25	21	17	17
其他非经营性收入 (费用)	2	0	0	-2	-1	0
税前利润	-30	-32	-2	-17	-25	-24
所得税费用	0	0	0	0	0	0
净利润	-30	-32	-2	-17	-25	-25
净利润增长	100%	1,500%	-88%	-32%	0%	19%
稀释后流通股数	1.04	0.57	0.49	0.39	0.07	0.01
股份同比变动 (YoY)	86%	16%	26%	457%	600%	--
每股收益 (摊薄)	-29.43	-56.29	-5.75	-45.66	-360.85	-2,521
每股收益增长率	4%	878.99%	-87%	-87%	-86%	-60%
自由现金流	-18	-14	2	-20	-23	-22
每股自由现金流	-17.3	-24.56	4.08	-51.28	-328.57	-2,200
毛利率	-1,400%	-8%	37.7%	22.22%	-100%	-200%
营业利润率	-3,300%	-124%	-3.27%	-55.55%	-459.99%	-800%
净利率	-3,000%	-128%	-3.27%	-62.96%	-500%	-833.33%
自由现金流利润率	-1,800%	-56%	3.27%	-74.07%	-459.99%	-733.33%
EBITDA	-32	-30	-1	-14	-23	-24
EBITDA 利润率	-3,200%	-120%	-1.63%	-51.85%	-459.99%	-800%
EBITDA 中的折旧与摊销	1	1	1	1	0	0
EBIT	-33	-31	-2	-15	-23	-24
EBIT 利润率	-3,300%	-124%	-3.27%	-55.55%	-459.99%	-800%
有效税率	0%	0%	0%	0%	0%	0%

Follow-Up Questions











